天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine

5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine Struktur
143653-61-6
CAS-Nr.
143653-61-6
Englisch Name:
5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine
Synonyma:
5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine;5’-O-(4,4-Dimethoxytrityl)-3’-deoxy-5-methyluridine;Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxy-5-methyl-
CBNumber:
CB54842139
Summenformel:
C31H32N2O7
Molgewicht:
544.6
MOL-Datei:
143653-61-6.mol

5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine Eigenschaften

Dichte
1.272±0.06 g/cm3(Predicted)
pka
9.55±0.10(Predicted)

Sicherheit

5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine Chemische Eigenschaften,Einsatz,Produktion Methoden

5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
SHANGHAI T&W PHARMACEUTICAL CO., LTD. 		+86-021-61551413 +8618813727289
 contact@trustwe.com China 5745 58
BOC Sciences 		16314854226; +16314854226
 inquiry@bocsci.com United States 19654 58
NewCan Biotech Limited 		+86-0571-86912261 +8613735419629
 sales@newcanbio.com China 9985 58
TargetMol Chemicals Inc.
support@targetmol.com United States 38669 58
T&W GROUP 021-61551611 13296011611
 contact@trustwe.com China 9895 58
Zhengzhou Granlen Sciences, ltd. 0371-85513397 +86-18610099868;
 info@granlen.com China 1841 58
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 24952 58
Beijing Qinling Pharmaceutical Co., Ltd. 010-61241352 18901327973
 834537306@qq.com China 5206 58
  • 5'-O-(4,4-Dimethoxytrityl)-3'-deoxy-5-methyluridine
  • Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxy-5-methyl-
  • 5’-O-(4,4-Dimethoxytrityl)-3’-deoxy-5-methyluridine
  • 143653-61-6
Copyright 2019 ? ChemicalBook. All rights reserved